Jurriaan Brouwer-Visser
2PUBLICATIONS
9CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (2)
Sort by Publication Date:
|Dec 09, 2024
Translational findings support regimen selection for first-in-human study of ubamatamab (MUC16 × CD3 bispecific antibody) in patients with recurrent ovarian cancer.Min Zhu, Priyanka Madia, Alison Crawford
|Mar 22, 2024
Molecular assessment of intratumoral immune cell subsets and potential mechanisms of resistance to odronextamab, a CD20×CD3 bispecific antibody, in patients with relapsed/refractory B-cell non-Hodgkin lymphoma.Jurriaan Brouwer-Visser, Nathalie Fiaschi, Raquel P Deering
Pageof 1

